Aggressive variants of prostate cancer – Are we ready to apply specific treatment right now?-Reference-Cited by-同舟云学术

Aggressive variants of prostate cancer – Are we ready to apply specific treatment right now?

Published:2019-05 Issue: Volume:75 Page:20-26
ISSN:0305-7372
Container-title:Cancer Treatment Reviews
language:en
Short-container-title:Cancer Treatment Reviews

Author:

Tsaur Igor^ORCID,Heidegger Isabel,Kretschmer Alexander,Borgmann Hendrik,Gandaglia Giorgio,Briganti Alberto,de Visschere Pieter,Mathieu Romain,Valerio Massimo,van den Bergh Roderick,Ost Piet,Mirvald Cristian,Tilki Derya,Ploussard Guillaume^ORCID,Surcel Cristian

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging,Oncology,General Medicine

Reference70 articles.

1. Cancer statistics, 2017;Siegel;CA: Cancer J Clin,2017

2. Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015;Gillessen;Ann Oncol: Off J Eur Soc Med Oncol,2015

3. Chemohormonal therapy in metastatic hormone-sensitive prostate cancer;Sweeney;New England J Med,2015

4. Abiraterone plus prednisone in metastatic, castration-sensitive prostate cancer;Fizazi;New England J Med,2017

5. Improving the outcome of patients with castration-resistant prostate cancer through rational drug development;Attard;Br J Cancer,2006

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The yin and yang of chromosomal instability in prostate cancer;Nature Reviews Urology;2024-02-02

2. Self‐Assembled nanoparticles of natural bioactive molecules enhance the delivery and efficacy of paclitaxel in glioblastoma;CNS Neuroscience & Therapeutics;2023-12-04

3. Landmarks in the evolution of prostate biopsy;Nature Reviews Urology;2023-01-18

4. Reinvestigation of Passerini and Ugi scaffolds as multistep apoptotic inducers via dual modulation of caspase 3/7 and P53-MDM2 signaling for halting breast cancer;RSC Advances;2023

5. Salvage Chemotherapy with Cisplatin, Ifosfamide, and Paclitaxel in Aggressive Variant of Metastatic Castration-Resistant Prostate Cancer;International Journal of Molecular Sciences;2022-11-29